Aptium Oncology

Aptium Oncology is AstraZeneca's outpatient cancer treatment chain in the United States, managing outpatient cancer centers at five hospitals in California, Florida, New Jersey, and New York, providing outpatient oncology management and consulting services. The company's revenue in 2011 was $224 million. Before the sale was completed, the company's revenue in 2012 was $43 million.